News
Voltalia SA: Availability of the half-year financial report
Voltalia SA: Availability of the half-year financial report
DGAP-News: Abivax presents first-half 2020 financial results and operations update
DGAP-News: Abivax presents first-half 2020 financial results and operations update
DGAP-News: Abivax gibt Halbjahresergebnisse 2020 und Update zur Unternehmensentwicklung bekannt
DGAP-News: Abivax gibt Halbjahresergebnisse 2020 und Update zur Unternehmensentwicklung bekannt
Voltalia SA: After a strong growth in the first half of 2020, Voltalia confirms its medium-term trajectory
Voltalia SA: After a strong growth in the first half of 2020, Voltalia confirms its medium-term trajectory
IKEA France & Voltalia unveil a new product: a simple and accessible self-assembly solar panel solution
IKEA France & Voltalia unveil a new product: a simple and accessible self-assembly solar panel solution
RUBIS: Great resilience in the face of Covid - EBITDA: down 11% - Net income: down 11%
RUBIS: Great resilience in the face of Covid - EBITDA: down 11% - Net income: down 11%
RUBIS: Availability of the 2020 half-year financial report
RUBIS: Availability of the 2020 half-year financial report
Edison Investment Research Limited: Edison issues outlook on Esker (ALESK)
Edison Investment Research Limited: Edison issues outlook on Esker (ALESK)
Voltalia signs a power sale contract with Brazilian utilities Copel for a new 260-megawatt solar plant
Voltalia signs a power sale contract with Brazilian utilities Copel for a new 260-megawatt solar plant
Pharnext and the Charcot-Marie-Tooth Association Enter Biomarker Research Collaboration
Pharnext and the Charcot-Marie-Tooth Association Enter Biomarker Research Collaboration
DGAP-News: Abivax gibt 2-Jahres-Daten zur Langzeitwirkung und Sicherheit aus der Phase-2a-Erhaltungsstudie mit ABX464 zur Behandlung von Colitis ulcerosa bekannt
DGAP-News: Abivax gibt 2-Jahres-Daten zur Langzeitwirkung und Sicherheit aus der Phase-2a-Erhaltungsstudie mit ABX464 zur Behandlung von Colitis ulcerosa bekannt
DGAP-News: ABIVAX: Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study
DGAP-News: ABIVAX: Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Voltalia sells a 28-megawatt ready-to-build wind project together with construction and maintenance services
Voltalia sells a 28-megawatt ready-to-build wind project together with construction and maintenance services
Showroomprive.com: Breakdown of SRP Groupe's capital
Showroomprive.com: Breakdown of SRP Groupe's capital
Voltalia completes the installation of solar shelters in France
Voltalia completes the installation of solar shelters in France
Voltalia SA: Total number of shares and voting rights in the share capital as of July 31, 2020
Voltalia SA: Total number of shares and voting rights in the share capital as of July 31, 2020
Voltalia wins 12 megawatts of new solar projects in Greece
Voltalia wins 12 megawatts of new solar projects in Greece
Showroomprive.com: Successful capital increase Showroomprivé raises 9.9 million euros
Showroomprive.com: Successful capital increase Showroomprivé raises 9.9 million euros
Voltalia starts the construction of the VSM 4 wind farm in Brazil
Voltalia starts the construction of the VSM 4 wind farm in Brazil
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 07/31/2020
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 07/31/2020
Showroomprive.com: APPROVAL OF THE SUPPLEMENT TO THE PROSPECTUS
Showroomprive.com: APPROVAL OF THE SUPPLEMENT TO THE PROSPECTUS
Kaufman & Broad SA: Further information following the press release from Promogim
Kaufman & Broad SA: Further information following the press release from Promogim